Gastric bezoar complication of Duodopa® therapy in Parkinson's disease, treated with Coca‐Cola®
- 7 June 2014
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 29 (8), 1087-1088
- https://doi.org/10.1002/mds.25930
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Systematic review: Coca‐Cola can effectively dissolve gastric phytobezoars as a first‐line treatmentAlimentary Pharmacology & Therapeutics, 2012
- Severe gastrointestinal complications in patients with levodopa/carbidopa intestinal gel infusionMovement Disorders, 2012
- Duodopa® treatment for advanced Parkinson's disease: A review of efficacy and safetyParkinsonism & Related Disorders, 2012
- Duodenal levodopa infusion for advanced Parkinson's disease: 12‐month treatment outcomeMovement Disorders, 2007
- Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implicationsThe Lancet Neurology, 2006
- Duodenal levodopa infusion in Parkinson's disease - long-term experienceActa Neurologica Scandinavica, 2001